Administering pinocembrin, a bioactive component found in propolis, demonstrated effectiveness against colitis by inhibiting the aberrant activation of toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) signaling in mice. This evidence concerns the gene TLR4 and colitis.